APA (7th ed.) Citation

JS, N., CB, L., AR, L., C, V., F, V., F, S., . . . JP, F. (2026). GLP-1 Receptor Agonists for the Prevention of New-Onset Heart Failure: A Systematic Review and Meta-Analysis of Placebo-Controlled Randomized Clinical Trials. Obesity reviews : an official journal of the International Association for the Study of Obesity, 27(4), e70043. https://doi.org/10.1111/obr.70043

Chicago Style (17th ed.) Citation

JS, Neves, Lobato CB, Leite AR, Vale C, Vasques-Nóvoa F, Saraiva F, Leite-Moreira A, Holst JJ, and Ferreira JP. "GLP-1 Receptor Agonists for the Prevention of New-Onset Heart Failure: A Systematic Review and Meta-Analysis of Placebo-Controlled Randomized Clinical Trials." Obesity Reviews : An Official Journal of the International Association for the Study of Obesity 27, no. 4 (2026): e70043. https://doi.org/10.1111/obr.70043.

MLA (9th ed.) Citation

JS, Neves, et al. "GLP-1 Receptor Agonists for the Prevention of New-Onset Heart Failure: A Systematic Review and Meta-Analysis of Placebo-Controlled Randomized Clinical Trials." Obesity Reviews : An Official Journal of the International Association for the Study of Obesity, vol. 27, no. 4, 2026, p. e70043, https://doi.org/10.1111/obr.70043.